Approval · Notice of Compliance 15062 · 2013
IPG-DONEPEZIL: Notice of Compliance 15062
Issued December 27, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15062
- Date
- December 27, 2013
- Company
- International Pharmaceutical Generics LtdOttawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Cholinesterase inhibitor
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-DONEPEZIL | 02398885 | Approved |
| IPG-DONEPEZIL | 02398893 | Approved |
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB